A Phase Diagram for Crystallization of a Complex Macromolecular Assembly

Crystallization of biological molecules has high potential to solve some challenges in drug manufacturing. Thus, understanding the process is critical to efficiently adapting crystallization to biopharmaceutical manufacturing. This article describes phase behavior for the solution crystallization of recombinant adeno-associated virus (rAAV) capsids of serotypes 5, 8, and 9 as model biological macromolecular assemblies. Hanging-drop vapor diffusion experiments are used to determine the combined effects of pH and polyethylene glycol (PEG) and sodium chloride concentrations in which full and empty capsids nucleate and grow. Full and empty capsids show different crystallization behavior although they possess similar capsid structure and similar outer morphology with icosahedral symmetry and 2-fold, 3-fold, and 5-fold symmetry. The differential charge environment surrounding full and empty capsids is found to influence capsid crystallization. The crystal growth rate is found to be affected by the mass of the macromolecular assembly rather than the structure/shape of the macromolecular assembly. The regions of precipitant concentrations and pH in which crystallization occurs are found to be different for different rAAV serotypes and for full and empty capsids for each serotype. Depending on the precipitant concentrations and the rAAV serotype, a variety of complex crystal morphologies are formed and a variety of non-crystallization outcomes such as unidentified dense solid-phase/opaque crystals and an oil/dense phase is observed. The well-defined dense phase/oil is found to be converted into a solid phase over a long period of time. Trends in the crystallization of full and empty capsids between serotypes is observed to be altered by the extent of post-translational modifications (PTMS) associated with the massive macromolecular proteinaceous assembly.